Top compounds associated with response to KMT2B


Feature Type Standardized
Nominal ANOVA
mRNA BRD-K34222889 CTRPv2 pan-cancer AAC 0.15 2e-05
mRNA CD-437 CTRPv2 pan-cancer AAC 0.15 3e-05
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 3e-05
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 5e-05
mRNA LY-2183240 CTRPv2 pan-cancer AAC 0.14 5e-05
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.15 6e-05
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.15 7e-05
mRNA Axitinib CTRPv2 pan-cancer AAC 0.15 7e-05
mRNA CCT036477 CTRPv2 pan-cancer AAC 0.14 8e-05
mRNA Mitomycin-C CTRPv2 pan-cancer AAC 0.14 8e-05
Download CSV